X4 Pharmaceuticals Statistics
Total Valuation
XFOR has a market cap or net worth of $191.45 million. The enterprise value is $135.51 million.
Market Cap | 191.45M |
Enterprise Value | 135.51M |
Important Dates
The next estimated earnings date is Friday, May 10, 2024, before market open.
Earnings Date | May 10, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
XFOR has 167.94 million shares outstanding. The number of shares has increased by 179.91% in one year.
Shares Outstanding | 167.94M |
Shares Change (YoY) | +179.91% |
Shares Change (QoQ) | +1.02% |
Owned by Insiders (%) | 0.83% |
Owned by Institutions (%) | 61.32% |
Float | 130.20M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 3.75 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.34, with a Debt / Equity ratio of 1.14.
Current Ratio | 5.34 |
Quick Ratio | 5.02 |
Debt / Equity | 1.14 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -16.50 |
Financial Efficiency
Return on equity (ROE) is -170.10% and return on invested capital (ROIC) is -98.30%.
Return on Equity (ROE) | -170.10% |
Return on Assets (ROA) | -65.40% |
Return on Capital (ROIC) | -98.30% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.09M |
Employee Count | 93 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, XFOR has paid $78,000 in taxes.
Income Tax | 78,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.33% in the last 52 weeks. The beta is 0.46, so XFOR's price volatility has been lower than the market average.
Beta (1Y) | 0.46 |
52-Week Price Change | -24.33% |
50-Day Moving Average | 1.13 |
200-Day Moving Average | 1.06 |
Relative Strength Index (RSI) | 44.80 |
Average Volume (30 Days) | 2,497,898 |
Short Selling Information
The latest short interest is 12.26 million, so 7.30% of the outstanding shares have been sold short.
Short Interest | 12.26M |
Short Previous Month | 12.33M |
Short % of Shares Out | 7.30% |
Short % of Float | 9.42% |
Short Ratio (days to cover) | 2.97 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -107.52M |
Pretax Income | -101.09M |
Net Income | -101.17M |
EBITDA | -93.32M |
EBIT | -95.31M |
Earnings Per Share (EPS) | -$0.57 |
Balance Sheet
The company has $114.22 million in cash and $58.28 million in debt, giving a net cash position of $55.94 million or $0.33 per share.
Cash & Cash Equivalents | 114.22M |
Total Debt | 58.28M |
Net Cash | 55.94M |
Net Cash Per Share | $0.33 |
Equity / Book Value | 51.10M |
Book Value Per Share | 0.30 |
Working Capital | 99.21M |
Cash Flow
In the last 12 months, operating cash flow was -$96.51 million and capital expenditures -$60,000, giving a free cash flow of -$96.57 million.
Operating Cash Flow | -96.51M |
Capital Expenditures | -60,000 |
Free Cash Flow | -96.57M |
FCF Per Share | -$0.54 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
XFOR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -179.91% |
Shareholder Yield | -179.91% |
Earnings Yield | -52.84% |
FCF Yield | -50.44% |
Analyst Forecast
The average price target for XFOR is $3.00, which is 164.32% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $3.00 |
Price Target Difference | 164.32% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 14, 2019. It was a reverse split with a ratio of 1:6.
Last Split Date | Mar 14, 2019 |
Split Type | Reverse |
Split Ratio | 1:6 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |